Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells

Allergy. 2015 Apr;70(4):408-19. doi: 10.1111/all.12576.

Abstract

Background: A detailed characterization of human oral immune cells is needed to better understand local mechanisms associated with allergen capture following oral exposure.

Methods: Oral immune cells were characterized by immunohistology and immunofluorescence in biopsies obtained from three healthy individuals and 23 birch pollen-allergic patients with/without oral allergy syndrome (OAS), at baseline and after 5 months of sublingual allergen immunotherapy (AIT).

Results: Similar cell subsets (i.e., dendritic cells, mast cells, and T lymphocytes) were detected in oral tissues from healthy and birch pollen-allergic individuals. CD207+ Langerhans cells (LCs) and CD11c+ myeloid dendritic cells (DCs) were found in both the epithelium and the papillary layer of the Lamina propria (LP), whereas CD68+ macrophages, CD117+ mast cells, and CD4+ /CD8+ T cells were rather located in both the papillary and reticular layers of the LP. Patterns of oral immune cells were identical in patients with/without OAS, except lower numbers of CD207+ LCs found in oral tissues from patients with OAS, when compared to OAS- patients (P < 0.05). A 5-month sublingual AIT had a limited impact on oral immune cells, with only a significant increase in IgE+ cells in patients from the active group. Colocalization experiments confirmed that such IgE-expressing cells mostly encompass CD68+ macrophages located in the LP, and to a lesser extent CD207+ LCs in the epithelium.

Conclusion: Two cell subsets contribute to antigen/allergen uptake in human oral tissues, including (i) CD207+ LCs possibly involved in the physiopathology of OAS and (ii) CD68+ macrophages likely critical in allergen capture via IgE-facilitated mechanisms during sublingual AIT.

Keywords: IgE; birch allergy; macrophages; mucosal immunity; sublingual allergen immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens / immunology*
  • Antigen-Presenting Cells / immunology*
  • Antigen-Presenting Cells / metabolism
  • Antigens, Surface / metabolism
  • Betula*
  • Biomarkers
  • Biopsy
  • Case-Control Studies
  • Female
  • Gene Expression
  • Gingiva / immunology
  • Gingiva / metabolism
  • Gingiva / pathology
  • Humans
  • Hypersensitivity / diagnosis
  • Hypersensitivity / immunology
  • Hypersensitivity / therapy
  • Immunoglobulin E / genetics
  • Immunoglobulin E / immunology
  • Immunoglobulin E / metabolism
  • Immunophenotyping
  • Macrophages / immunology
  • Macrophages / metabolism
  • Male
  • Mast Cells / immunology
  • Mast Cells / metabolism
  • Pollen / immunology*
  • Rhinitis, Allergic, Seasonal / diagnosis
  • Rhinitis, Allergic, Seasonal / immunology*
  • Rhinitis, Allergic, Seasonal / therapy
  • Sublingual Immunotherapy
  • Syndrome
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism

Substances

  • Allergens
  • Antigens, Surface
  • Biomarkers
  • Immunoglobulin E